HOME COMPANY OUR VALUE PROJECTS NEWS EVENTS ABOUT MEDSIR CONTACT US! Slider Mar2017 01 Slider Mar2017 02 Slider Mar2017 03 Come listen to MedSIR Founders Maria Campos, Dr. Javier Cortés, and Dr. Antonio Llombart speak about the MedSIR concept and how we are currently optimizing clinical research in Oncology. Don’t miss Dr. José Perez, Breast Cancer Specialist, speaking about the role MedSIR plays in his everyday research. WELCOME TO MEDSIR! Here we are dedicated to the design and management of clinical trials involving some of the most important current drugs in Oncology such as osimertinib, pembrolizumab, pertuzumab, T-DM1, olaparib, niraparib, eribulin, palbociclib, fulvestrant, radium-223 and many more and we’d be thrilled to help you transform your idea into a high-level strategic clinical trial by applying our simple method: First off, you confidentially send us your idea… a few lines, or a short synopsis is all we need. Then, your idea will be reviewed by our network of cancer experts while our statistician develops a realistic scenario for the study to be carried out. Lastly, we confidentially present the proposal to a potential funder, negotiating a win-win situation that satisfies all parties. If the project is approved, you will join our team and play a lead role in all study aspects all the way through to the publication of study results. Meanwhile, our clinical operations team professionally manages the trial, respecting ISO 9001-certified quality, while placing a major focus on accrual timelines: The faster we move, the quicker we can produce results and improve patient lives. HELPING PATIENTS WORLDWIDE 1.243 patients SUCCESSFULLY ENROLLED FOLLOW US ON TWITTER FEED Follow @medsir2012 MedSIR @medsir2012 4 days ago Luces, cámara y acción! 🎬 Nuestro #MedSIRTeam se encuentra haciendo una gran labor en la sesión de CICOM en el #SEOM2018 #CancerResearch #investigacion #clinicaltrial https://t.co/BM12aKp7Bw View on Twitter 1 3 MedSIR @medsir2012 5 days ago Les presentamos al @GrupoCICOM y los ponentes de hoy. ¡Bienvenidos! #SEOM2018 #SEOM18 #MedSIReverywhere https://t.co/q42GedZPIo View on Twitter 4 8 INSTAGRAM FEED Follow us on Instagram FACEBOOK FEED MedSIR It is a great pleasure to welcome you to MedSIR, a private company founded by Oncology experts in 2012. Together, not only we do make up an international team with many years of high-level clinical and research experience, but also, and even more importantly, a team that is passionate about helping you, our clients, to get your best and most innovative treatments to our patients as efficiently and quickly as possible. Along the way, we strive to improve our scientific knowledge of this complex disease and the large array of available treatments, producing a win-win-win situation for your company, for our patients, and for the scientific community. This endeavor requires strong and creative minds to generate novel, out-of-the-box ideas, as well as a high-level operations team behind the scenes that brings these strategic ideas to life. At MedSIR we have the complete package that is changing the way IIS Research is being done. Bring your idea to life💡 Design & Management of Clinical Trials 📊 Medica Scientia Innovation Research (MedSIR) MedSIR5 days ago Hoy MedSIR está en la sesión de CICOM de #SEOM2018. Os dejamos aquí el link de nuestra encuesta de Excelencia en Investigación Clínica: https://gabrielsalges.typeform.com/to/l3sQiw #SEOM #SEOM18 #MedSIR 6 1 View on Facebook MedSIR5 days ago La cantidad de la proteína PD1 presente en un tumor indica si se puede tratar con éxito con fármacos de inmunoterapia, según una investigación liderada desde el hospital Clínic presentada en la revista Annals of Oncology. #Cáncer #Oncología #Inmunoterapia Un test genómico predice qué pacientes con cáncer responderán a la inmunoterapia La cantidad de la proteína PD1 presente en un tumor indica si se puede tratar con éxito con fármacos de inmunoterapia, según una investigación liderada desde el hospital Clínic presentada en la... lavanguardia.com 21 View on Facebook FOLLOW US ON COMPANY · Welcome · Our Vision · The MedSIR Team · From Barcelona… OUR VALUE · Scientific Board · Strategic Trial Design · Idea Submission · Commitment to Quality PROJECTS · Current Projects · Closed Projects · Publications · #medsireverywhere NEWS & EVENTS · News · Events ABOUT · FAQ · Testimonials · Contact Us! GET OUR MONTHLY NEWSLETTER! First name: Last name: Email address: Before you sign the application, you should read the basic information on data protection listed here I accept the sending of periodic commercial communications by MEDICA SCIENTIA INNOVATION RESEARCH, SL Please choose your area of interest: Healthcare/Academic Professional Pharma/Biotech Professional Other Companies Action to perform: Subscribe Unsubscribe © 2018 MedSIR | Privacy Policy | Legal Notice | Official Notice | Cookie Policy | info@medsir.org We'll assume you're ok with this, but you can opt-out if you wish.Accept